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ABSTRACT 
This study aimed to verify whether the “live low, train high” approach is 
beneficial for endurance and/or anaerobic cycling performance. Sixteen well-
trained athletes completed 90 min of endurance training (60-70% of heart rate 
reserve) followed by two 30-s all-out sprints (Wingate test), daily for 10 
consecutive days. Nine subjects (IHT group) trained with an FIO2 set to 
produce arterial oxygen saturations of ~88% to ~82%, while 7 subjects 
(placebo group) trained while breathing a normal gas mixture (FIO2 = 0.21). 
Four performance tests were conducted at sea-level including a familiarisation 
and baseline trial, followed by repeat trials at 2 and 9 days post-intervention. 
Relative to the placebo group mean power during the 30-s Wingate test 
increased by 3.0% (95% Confidence Limits, CL ± 3.5%) 2 days, and 1.7% (± 
3.8%) 9 days post-IHT. Changes in other performance variables (30-s peak 
power, 20-km mean power, 20-km oxygen cost) were unclear. During the time 
trial the IHT participants‟ blood lactate concentration, RER and SpO2 relative 
to the placebo group, was substantially increased at 2 days post-intervention. 
The addition of IHT into the normal training programme of well-trained 
athletes produced worthwhile gains in 30-s sprint performance possibly 
through enhanced glycolysis. 
 
 
INTRODUCTION 
 
An increasingly popular method of altitude training is intermittent hypoxic 
training (IHT); a “live low-train high (LLTH)”  approach, where athletes live at 
or near sea level but train in hypoxic conditions similar to higher altitudes 
(~2,500 to 3850m) (Geiser et al. 2001). IHT is commonly incorporated into an 
athlete‟s training schedule in preference to living at natural altitude and 
training at or near sea-level (live high-train low; LHTL) due to the minimal 
travel, low expense and negligible disruption to training and daily life.  
 
It has been demonstrated that the LHTL method improves sea-level 
endurance performance in both sub-elite (Levine & Stray-Gundersen 1997) 
and elite athletes (Brugniaux et al. 2006). The exact mechanisms responsible 
for enhanced endurance performance following LHTL are controversial (see 
point-to-point discussion: Journal of Applied Physiology 2005 99:2053-2058). 
(Levine & Stray-Gundersen 2005) argue that the primary mechanism 
responsible for improved sea-level endurance performance following 
repeated, prolonged exposure to hypoxia is an enhanced erythropoietic 
response, which results in an elevated red blood cell volume and resultant 
enhanced rate of oxygen transport. In contrast, (Gore & Hopkins 2005) 
emphasised that an improvement in exercise economy is more likely to be 
responsible for enhanced performance following LHTL, although this notion is 
not supported in a recent report (Truijens et al. 2008). Although the exact 
mechanisms remain debateable, it appears that living at natural altitude and 
training closer to sea-level improves sea-level endurance performance in 
most cases (Brugniaux, Schmitt 2006; Chapman et al. 1998; Levine & Stray-
Gundersen 1997; Schmitt et al. 2006; Stray-Gundersen et al. 2001; Wehrlin et 
al. 2006). 
 
The efficacy of IHT for the enhancement of sea-level performance, however, 
is more controversial. Several studies have reported an enhanced athletic 
performance following IHT (Dufour et al. 2006; Ponsot et al. 2006) although a 
number have failed to demonstrate any significant alteration in post-IHT 
performance measures (Morton & Cable 2005; Roels et al. 2007). 
 
These conflicting results may be due to methodological differences including 
the duration and intensity of the hypoxic stimulus, type and intensity of 
exercise, subject training status, and the time-point following the IHT 
procedure at which performance was determined. The current IHT research 
has focused on simulating a specific altitude (2500m – 6000m) despite the 
knowledge that athletes have a highly variable response to hypoxia (Ainslie et 
al. 2007). In addition to IHT, much of the research into the effects of hypoxia 
has involved exposing individuals intermittently to hypoxia while seated at rest 
(intermittent hypoxic exposure, IHE). Recent IHE studies have individualised 
the hypoxic stimulus by reducing the arterial oxygen saturation (SpO2) to a set 
level (Marshall et al. 2008; Wood et al. 2006). The effectiveness of this 
methodology, however, remains unclear as IHE has been found to enhance 
(Wood, Dowson 2006) or have no effect (Marshall, Hamlin 2008) on aerobic 
performance, and is yet to be utilised during exercise training in hypoxia (IHT). 
 
In addition to potentially improving endurance performance, IHE and IHT may 
also benefit anaerobic exercise performance (Bonnetti et al. 2006; Hendriksen 
& Meeuwsen 2003), possibly via increases in muscle buffering capacity (Gore 
et al. 2001) and glycolytic enzyme activity (Katayama et al. 2004). IHE has 
been found to increase repeated kayak sprint power by 8.3 ± 6.7% and 6.8 ± 
5.2% (mean ± 90% confidence limits) for mean and peak power respectively 
(Bonnetti, Hopkins 2006) and repeated sprint run times by ~1 – 7 % (Wood, 
Dowson 2006) 3 days following hypoxia exposures. Similarly, 10 days of IHT 
at a simulated altitude of 2500m improved anaerobic mean (4.1 %) and peak 
(3.8 %) cycling power at 9 days post-intervention compared to the placebo 
sea-level  training group (Hendriksen & Meeuwsen 2003). Other studies, 
however, have reported no beneficial effect of IHT (Morton & Cable 2005) or 
IHE (Tadibi et al. 2007) on anaerobic performance over and above that of 
training closer to sea-level. 
 
 
OBJECTIVES 
 
The majority of studies to date identifying the effects of IHT on anaerobic 
performance have involved endurance training at altitude with no inclusion of 
anaerobic training. The aim of the present single-blinded, randomised 
placebo-controlled study therefore was to determine the effect of 10 
consecutive days of combined aerobic and anaerobic cycle training at a set 
SpO2 on both aerobic and anaerobic performance. 
 
 
METHODOLOGY 
 
Subjects 
Sixteen athletes from a variety of cycling backgrounds (8 road cyclists, 3 
mountain bikers, 1 triathlete and 4 multisport athletes [athletes that mainly 
compete in run, cycle and kayak events]) volunteered to participate in the 
present study, all of whom were well trained and competed at regional or 
national level in their specific discipline. The research was conducted over the 
winter period when the cyclists were in the base phase of their training (pre-
season). The study was approved by the Lincoln University Human Ethics 
Committee and conformed to the standards set by the Declaration of Helsinki. 
Informed voluntary written consent was obtained from each subject prior to 
the start of the study. Subject characteristics are presented in Table 1. 
 
Table 1. Characteristics and baseline measures of performance of athletes in the two training groups. 
 Placebo 
(n = 7) 
IHT 
(n = 9) 
Age (y) 38.7 ± 8.6 29.6 ± 12.3 
Body mass (kg) 76.7 ± 12.3 76.6 ± 11.1 
Height (m) 1.78 ± 0.1 1.72 ± 0.1 
Sex 6 male 1 female 8 male 1 female 
Training (Trimp.d
-1
) 224  ± 177 176  ± 82 
Wingate 30-s mean power (W.kg
-1
) 8.5 ± 0.8 8.8 ± 0.9 
Wingate 30-s peak power (W.kg
-1
) 14.0 ± 2.0 13.6 ± 2.9 
20-km mean speed (km.h
-1
) 35.7 ± 3.4 37.2 ± 3.3 
20-km mean power (W.kg
-1
) 3.2 ± 0.7 3.5 ± 0.6 
Oxygen cost (ml.W
-1
) 12.6 ± 3.1 13.7 ± 1.0 
Values are mean ± between subject standard deviation. Trimp; Training Impulse. 
 
 
All subjects were healthy, free from injury, lived at sea level and had not been 
resident at altitude within the past 6 months. As some authors suggest 
maximal exercise performance is unaffected by changes in the menstrual 
cycle (Beidleman et al. 1999) there was no attempt to test the female athletes 
in this study in the same phase of their menstrual cycle. 
 
Subjects were matched for initial 20-km cycle time trial performance (i.e. time 
to complete the 20-km), then randomly divided into two groups: an intermittent 
hypoxic training group (IHT, n=9) and a control group (placebo, n=8). Due to 
illness, one placebo group subject had to withdraw from the study.  
 
Study design 
The study, based on a training protocol used previously (Hendriksen & 
Meeuwsen 2003), was a single-blind placebo-controlled trial. Subjects 
performed four main trials including a familiarisation, baseline, and two post-
training trials. The baseline trial was performed 1 week after the familiarisation 
trial and two days prior to beginning IHT or placebo training. The IHT group 
trained at simulated altitude (normobaric hypoxia) whereas the placebo group 
underwent the same training protocol at sea level (normobaric normoxia) on 
10 consecutive days. The post-training trials were completed 2 and 9 days 
after the training period. The main trials involved a 30-s Wingate anaerobic 
test followed 1 h later by a 20-km cycle time trial.  
 
Subject preparation 
The subjects were asked to refrain from intense exercise for 24 h prior to each 
main trial. Subjects also recorded their dietary intake prior to the first trial to 
allow replication of diet prior to subsequent trials. Subjects were provided with 
a pre-test meal (2 g carbohydrate/kg body mass of Sustagen® Sport, Nestlé, 
Victoria, Australia) which was consumed, along with 500 mL water, 2 h before 
arriving at the laboratory. Iron tablets (170 mg ferrous glucomate and 40 mg 
ascorbic acid; Healtheries Iron & Vitamin C, Auckland) were provided to 
subjects from one week prior to the familiarisation trial, as altitude-induced 
erythropoiesis is unlikely to occur in an iron-deficient state (Stray-Gundersen 
et al. 1992). Subjects consumed one tablet, twice a day with food throughout 
the study. The subjects were asked to avoid additional training for 2 h before 
and after each training session.   
 
Resting venous blood samples were drawn from an antecubital vein of seated 
subjects in a fasted state prior to training (baseline) and ~2 (post-2) and ~9 
(post-9) days post training. Blood samples were drawn at the same time for 
each subject, in the morning prior to breakfast, when subjects were in a fasted 
state. Samples were assayed by an independent professional testing 
laboratory (Southern Community Laboratories, Christchurch, New Zealand) 
for haemoglobin, haematocrit, reticulocytes (XE-2100, Sysmex, Japan), 
serum iron, serum ferritin and % ferritin saturation (917, Hitachi, Japan).  
 
Training 
Subjects trained on their personal road bikes on 10 consecutive days, either 
at simulated altitude (IHT) or sea level (placebo). The bikes were mounted on 
a stationary trainer (CycleOps Fluid 2, Madison, WI, USA) and tyre pressure 
standardised to 120 Psi; bike positioning and tyre pressure were replicated at 
each training session. The aerobic component of the training lasted 90 min 
and was performed at 60% -70% of the heart rate reserve. In order to have 
subjects work at the same relative intensity the IHT group‟s target heart rate 
was adjusted to take account of the natural fall in maximal heart rate with 
decreasing FIO2 (Richalet 1992). A regression equation which describes the 
decrease in chronotropic drive during hypoxia, y (% of sea-level HRmax) = 116 
– 0.0057x (x = altitude in meters, or SpO2), was used to predict maximal heart 
rate for the heart rate reserve calculation (Richalet 1992). Following the 
continuous cycling, subjects completed two 30-s Wingate tests, separated by 
5 min, on an electromagnetically-braked cycle ergometer (Velotron, 
RacerMate Inc, Seattle, USA).  
 
During training, subjects received either a normobaric hypoxic gas (IHT 
group) or normobaric normoxic gas (placebo group) via the GO2Altitude® 
hypoxicator system (Biomedtech, Victoria, Australia). After calibrating the 
equipment at the start of each training session, the hypoxic or placebo gas 
was sent to two 100 L Douglas bags connected in series. Subjects breathed 
from the bags via a leak-free respiratory mask (Hans-Rudolph 8980, Knasas 
City, MO, USA) attached to a one-way non-rebreathing valve (Hans-Rudolph 
2700, Kansas City, MO, USA). To allow sufficient time for adaptation the 
oxygen concentration in the hypoxic gas was progressively reduced over the 
10-day training period in the IHT group. The fraction of inspired oxygen (FIO2) 
was manually adjusted by the researcher to allow a similar hypoxic stimulus 
for each subject. SpO2 levels were ~88% on days 1-2, ~84% on days 3-4, and 
~82% on days 5-10 (the equivalent of 3200m, 4000m and 4400m altitude, 
respectively). The rationale for this protocol is purported to provide a hypoxic 
stimulus harsh enough to induce acclimatization (Julian et al. 2004). The 
progressive decrease in FIO2 over the course of the study is to provide 
maximal tolerable hypoxic stress by the end of the training period, but allow 
progressive acclimatization to minimize symptoms of hypoxic stress and 
improve tolerance. Subjects were unable to view their inspired oxygen 
concentration or blood saturation levels during training and we are confident 
that the blinding procedure worked, as participants were unable to determine 
which group they were in when asked at the end of the study. SpO2, FIO2 and 
heart rate (HR) were recorded every 5 minutes. 
 
Subjects were provided with daily logs in which they recorded their daily 
training information (frequency, intensity, duration and type) as well as their 
subjective ratings of stress, fatigue, muscle soreness, quality of sleep and 
quality of training performance. To compare total training load among groups, 
training impulse (TRIMP) was calculated which was expressed as a product of 
stress (duration of activity) and strain (subjective rating of training intensity). 
Subjects reported their subjective feelings with the use of the following 5-point 
Likert-type scale; excellent =1, good =2, average =3, poor =4, very poor =5. 
Performance tests 
Hydration status (urine specific gravity; Bayer Diagnostics Multistix®, 
Leverkusen, Germany) and nude body mass were determined on arrival at 
the laboratory. Anaerobic and aerobic performances were then evaluated via 
a 30-s Wingate Anaerobic Test and a 20-km time trial, respectively. Both of 
these tests were conducted on the Velotron Pro ergometer (Racermate Inc., 
Seattle, WA). During the performance tests subjects consumed no food but 
were able to drink water ad libitum. The Wingate test was selected as it is the 
most widely used anaerobic performance test and commonly used on well-
trained athletes. We followed the standard instructions from the Velotron 
manufacturers (Racermate Inc., Seattle, WA), which are based on the original 
recommendations of (Inbar et al. 1996). Before each test factory calibration 
was verified, using the Accuwatt „run down‟ verification programme 
(Racermate Inc., Seattle, WA). The Velotron settings (seat, handle bar height 
and horizontal position) were adjusted during the familiarisation trial to match 
the subjects‟ personal road bike settings as closely as possible. These 
settings were then noted and replicated for each main trial. The gear ratios of 
the subjects‟ road bike were entered into the Velotron software resulting in a 
laboratory cycle ergometer as similar to their personal road bike as possible. 
 
After a 10 min self-selected warm-up, interspersed with 3 maximal sprints 
lasting ~5 s, subjects performed a 30 s Wingate test (Velotron Wingate 
software, version 1.0, Racermate Inc., Seattle, WA) in which they pedalled 
maximally against a constant load (males, 9.8% body mass; females, 9.5% 
body mass) while seated. The load was applied after an initial acceleration 
phase of 3 s. Final HR and SpO2 were recorded by the researcher and the 
Velotron software calculated peak and mean power output (W). The Wingate 
test was followed by light pedalling for 5-10 min followed by 50-55 min 
passive recovery.  
 
Following recovery, baseline data was collected (ventilation and expired 
gases, SpO2, HR and blood lactate concentration) followed by a 10-min self-
selected warm up for the time trial. Subjects completed the time trial from a 
standing start, on a gear ratio previously selected during the familiarisation 
trial. During the time trial subjects were able to change gear when they 
wished, as they would on their road bike. Subjects were informed of distance 
covered at 5, 10, 15-km time points and then every 1-km through to 20-km but 
received no feedback on power output, heart rate, pedal cadence or 
performance time. The following measurements were taken at 5 km, 10 km, 
15 km and 20 km; ventilation and expired gases, HR, SpO2, blood lactate 
concentration and rating of perceived exertion (RPE).  
 
Physiological Measurements 
Ventilation and expired gases were measured breath-by-breath, and 
averaged every 5 s, for a period of ~2 min leading up to each measurement 
time point (for time trial data), or averaged every 1 s (for Wingate data) using 
a portable gas exchange system (MetaMax® 3B; Cortex Biophysik, Leipzig, 
Germany). The reported gas variables are the average of the final minute 
(time trial) or 30-s (Wingate test) of this gas collection. Oxygen consumption 
(V O2), minute ventilation (V E), end-tidal CO2 (PETCO2) and respiratory 
exchange ratio (RER) were calculated. Since the time trial is similar to a 
steady state test in that the subjects show an initial increase in speed and 
power over the first minute or so and then tend to maintain a relatively stable 
power output until the final „sprint‟ in the last 1-2 minutes of the test we have 
been able to calculate oxygen cost. For each subject, the oxygen cost of 
exercise, expressed as mL of oxygen per watt (mL/W), was calculated for the 
last minute of each of the 4 stages (5, 10, 15 and 20 km), then averaged. 
Before testing, the gas analyser was calibrated for volume (Hans Rudolph 
5530 3 L syringe; Kansas City, MO, USA) and gas composition (15% O2 and 
5% CO2). 
 
During the performance tests and training sessions HR was recorded 
continuously by means of a HR monitor (S610; Polar, Kempele, Finland). 
Arterial oxygen saturation was monitored manually by the researcher (Sport-
Stat, Nonin Medical, Minneapolis, MN). Subject‟s perceived exertion (RPE) 
was recorded with the use of a Borg scale (6-20). Blood lactate concentration 
was determined from a finger-prick sample, analysed using a portable lactate 
analyser (Lactate Pro, Arkray Inc, Kyoto, Japan). 
 
Statistical analyses 
Changes in the mean of the variables and standard deviations representing 
the between- and within-subject variability were estimated using a mixed 
modelling procedure (Proc Mixed) in the Statistical Analysis System (Version 
8.0, SAS Institute, Cary NC). We analysed the natural logarithm of each 
measure to reduce any effects in nonuniformity of error and to obtain changes 
in measures and errors as percentages. The fixed effects were trial (pre, 
post2 post9), group (IHT, placebo) and their interaction. The random effects 
were subject variance, residual variance, and additional within-subject 
variance for the two post-exposure trials combined for the IHT group. 
Chances that the true effects were substantial was estimated with a 
spreadsheet (Hopkins 2006), when a value for the smallest worthwhile effect 
is entered. We used a value of 1% for the performance measures, because 
this has been shown to represent the smallest worthwhile enhancement for 
cyclists competing in track or time trial events (Paton & Hopkins 2001) and 
has been used by previous researchers. For non-performance measures we 
chose 0.20 standardized units (change in mean divided by the between-
subject SD at baseline) as the smallest worthwhile change (Cohen 1988). To 
make inferences about the true (population) values of the effect of IHT on 
performance, p values and statistical significance were not used. Instead, 
uncertainty in the estimate of changes were presented as 95% confidence 
intervals and as likelihoods that the true value of the effect is a substantial 
enhancement or impairment. The relationships between parameters were 
determined by simple linear regression analysis. 
 
 
RESULTS 
 
Hypoxic exposure 
The placebo group‟s mean SpO2 during the training sessions remained 
between 94 – 95 %, whereas the IHT group‟s SpO2 decreased during training 
from 88.8 ± 1.8 % (mean ± SD), on day 1 to 83.5 ± 3.1 %, on day 10. The 
FIO2 required to maintain the SpO2 at this lowered level for the IHT group 
dropped from  0.17 ± 0.01 on day 1, to 0.14 ± 0.02, on day 10 (Figure 1, IHT 
group only). 
 
Training 
Both groups decreased their normal road training volume during the 10-day 
intervention period to accommodate the experimental training loads required 
for the study. We found no substantial difference in the training volume either 
between or within the groups before, during or after the study (placebo group 
224 ± 177, 221 ± 49, 145 ± 80; IHT group 176 ± 82, 203 ± 40, 165 ± 55 
Trimps.d-1 for pre, during and post-intervention respectively). However, 
because of the considerable variation in training we decided to examine 
whether differences in training load (Trimp) had any influence on performance 
outcomes. To do this we used the Trimp data as a covariate in the 
performance analysis as suggested by (Hopkins 2006). To investigate the 
effects of training load on the performance at 2 days post intervention we 
averaged the training data completed the week before and the 10 days during 
the intervention period. Similarly, we used the post-intervention Trimp data to 
investigate the effects of training on performance 9 days post intervention. 
Adjusting for training load in this way had little effect on performance 
outcomes with all measures changing less than 0.8%. Therefore, it seems 
unlikely that differences in training load between groups had any influence on 
the outcomes of this study.  
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Figure 1. The oxygen concentration (FIO2) and arterial oxygen saturation 
(SpO2) during the 10-day training programme for the IHT group. Data are 
means and SD. 
 
 
Performance 
Time (min:sec) to complete the 20-km distance decreased in both groups over 
the study (33:53, 33:38, 33:27 for placebo, and 32:50, 32:29, 32:08 for the 
IHT, for baseline, post2 and post9 tests respectively). After adjusting for initial 
differences in baseline performance between groups (Hopkins et al. 2009) the 
IHT subjects were 11.8 ± 40.2 and 23.7 ± 46.4 s (mean ± SD) faster than the 
placebo subjects at 2 and 9 days post-intervention respectively. Table 2 
shows the mean changes in performance and economy measures for the 
placebo and IHT groups and the statistics for the difference in the changes. 
When differences in athletes initial ability between groups was controlled for 
by using the baseline performance measures as a covariate, a beneficial 
effect of IHT on mean 30-s power 2 days post-intervention was likely. This 
beneficial effect was unclear at 9 days post-intervention. Effects of IHT on 30-
s peak power, 20-km mean power and oxygen cost were unclear. Adjusting 
for subject‟s body weight had little effect on the performance outcomes. 
 
Standard deviations representing observed individual responses in 
performance at 2 and 9 days post-exposure were 30-s mean power, -2.9% (-
4.7-2.5%) (mean and 95% confidence interval) and -2.9 (-5.1-3.1%); 30-s 
peak power, 5.3% (-11.6-15.4%) and 10.1% (-10.1-18.9); 20-km mean power, 
-1.0% (-6.2-6.4%) and 10.8% (-5.3-16.8%); oxygen cost, -8.0% (-15.0-11.8%) 
and 5.4% (-13.2-17.4%) respectively. Variation in response between 
individuals, represented by a positive standard deviation, in some cases was 
large relative to the mean effect of IHT shown in Table 2. However, the 
uncertainty in both the positive and negative standard deviations suggests 
modest individual responses for all measures, relative to the mean effects, 
except for 30-s peak power which showed large individual responses. 
 
Observed standard error (typical or within-subject error) of measurement post-
intervention for the experimental measures were 30-s mean power, 2.4% and 
2.7%; 30-s peak power 7.1% and 6.5%; 20-km mean power, 3.6% and 2.6%; 
oxygen cost, 8.3% and 6.7% for 2 and 9 days post-intervention respectively. 
The 95% confidence limits for the true errors were ~ x/÷2.0 for all measures. 
 
Table 2. Mean change in performance and physiological measures post-training, and chances that the true 
differences in the changes are substantial. 
 % Change Chances that true differences 
 Days Post-   Difference; are substantial
a
 
 training IHT Placebo ± 95% CL % Qualitative inference 
30-s mean power 2 
9 
2.8 
2.2 
-0.2 
0.5 
3.0; ± 3.5 
1.7; ± 3.8 
91 
67 
Likely Positive 
Unclear 
30-s peak power 2 
9 
1.6 
7.3 
-1.1 
-1.3 
2.7; ± 11.6 
8.6; ± 12.5 
62 
89 
Unclear  
Unclear 
20-km mean power 2 
9 
2.7 
4.7 
0.7 
2.0 
2.0; ± 5.5 
2.7; ± 9.2 
65 
65 
Unclear  
Unclear 
20-km Oxygen cost 2 
9 
-4.0 
-3.6 
5.5 
2.6 
-10.1; ± 15.9 
-6.2; ± 17.3 
88 
73 
Unclear  
Unclear 
a
Based on a smallest substantial change of 1.0% for all measures. ± 95% CL: add and subtract this number to the 
mean effect to obtain confidence limits for the true difference. 
 
 
Physiological variables 
Relative to the placebo group the IHT group‟s post-pre blood lactate 
concentration was consistently elevated throughout the 20-km time trial 2 and 
9 days post-intervention (Table 3). When taking the average change in blood 
lactate concentration over the entire time trial, the IHT participants blood 
lactate concentration relative to the placebo group, increased substantially by 
1.7 mmol.L-1 (-0.6-3.9) (mean and 95% confidence interval)at 2 days and 1.5 
mmol.L-1 (-0.7-3.7) 9 days post-intervention. Changes in ventilation and 
PETCO2 were in most cases unclear. Compared to the placebo group the IHT 
group‟s RER during the time trial was elevated 2 days post-intervention. 
Similarly there were clear and substantial increases in SpO2 during the time 
trial in the IHT relative to the placebo group. When taking the average change 
in RER over the entire time trial, the IHT participants RER relative to the 
placebo group, increased by 0.08 (-0.01-0.17) at 2 days post-intervention but 
returned to similar levels by 9 days. Similarly when calculating the average 
change in SpO2 over the entire time trail, the IHT participants mean arterial 
oxygen saturation was elevated by 1.2% (0.01-2.4%) at 2 days and 0.9% (-
0.2-2.1%) 9 days post-intervention.  
 
When taking the average change in RER during the 30-s Wingate test, the 
IHT participants RER relative to the placebo group, showed a clear and 
substantial increase of 0.16 (-0.02-0.34) at 2 days post-intervention but 
returned to similar levels by 9 days post-exposure (0.02, -0.16-0.21). Changes 
in the other respiratory variables during the 30-s Wingate test were trivial or 
unclear. 
 
 
Table 3. Mean post-pre changes between treatments (IHT-placebo) in physiological variables at rest 
and during the 20-km time trial. 
 Days 
Post- 
 
Change ± 95% CL 
 training Rest 5-km 10-km 15-km 20-km 
Blood Lactate  
(mmol.L
-1
) 
2 
9 
0.8 ± 1.0* 
-0.1 ± 1.2 
2.5 ± 3.0* 
1.5 ± 2.9 
1.5 ± 2.7 
1.0 ± 2.5 
1.2 ± 2.6 
1.3 ± 2.6 
1.6 ± 2.9 
2.5 ± 2.9* 
Heart Rate 
(b.min
-1
) 
2 
9 
6.6 ± 13.5 
4.3 ± 13.1 
4.7 ± 7.6* 
0.1 ± 7.6 
-0.1 ± 9.1 
-0.4 ± 9.2 
4.8 ± 7.1* 
-0.2 ± 7.0 
0.7 ± 7.9 
0.2 ± 7.9 
V E  
(L.min
-1
) 
2 
9 
-1.3 ± 2.9 
-1.8 ± 3.2 
12.3 ± 18.7 
-4.9 ± 20.3 
9.2 ± 19.7 
0.6 ± 21.9 
4.7 ± 21.9 
9.8 ± 23.8 
-6.8 ± 15.1 
14.5 ± 16.6* 
V O2 
(L.min
-1
) 
2 
9 
-0.00 ± 0.10 
-0.08 ± 0.12 
0.13 ± 0.45 
-0.24 ± 0.48 
0.05 ± 0.64 
-0.03 ± 0.69 
-0.19 ± 0.58 
-0.05 ± 0.64 
-0.52 ± 0.52* 
-0.03 ± 0.59 
PETCO2 
(mmHg) 
2 
9 
2.8 ± 5.1 
-1.3 ± 5.5 
0.1 ± 3.6 
-0.4 ± 3.9 
0.1 ± 3.1 
-0.2 ± 3.4 
0.6 ± 4.9 
-1.5 ± 5.4 
0.9 ± 3.5 
-1.5 ± 4.0 
RER 2 
9 
-0.07 ± 0.13 
-0.02 ± 0.14 
0.10 ± 0.11* 
0.01 ± 0.12 
0.09 ± 0.09* 
0.01 ± 0.10 
0.11 ± 0.11* 
-0.01 ± 0.12 
0.05 ± 0.10 
0.04 ± 0.11 
SpO2  
(%) 
2 
9 
0.3 ± 1.2 
0.6 ± 1.2 
0.2 ± 2.3 
2.0 ± 2.3* 
1.7 ± 2.4 
1.7 ± 2.4 
1.8 ± 1.8* 
0.8 ± 1.8 
1.7 ± 2.5 
-0.8 ± 2.4 
*Clear and substantial changes between groups based on a smallest substantial change of 0.2 of the 
between-subject standard deviation for all physiological measures. VE, minute ventilation;  PETCO2, 
end-tidal CO2; RER, respiratory exchange ratio; SpO2, oxygen saturation of arterial blood; ± 95% CL: 
add and subtract this number to the mean effect to obtain confidence limits for the true difference. 
 
 
Blood measures 
Substantial increases resulting from IHT were likely for haemoglobin and very 
likely for haematocrit 2 days post-exposure (Table 4). The differences 
between groups in haemoglobin and haematocrit had decreased by 9 days 
post-intervention. Relative to the placebo group, reticulocytes in the IHT group 
were either likely (2 days) or very likely (9 days) to have increased post-
intervention. Substantial decreases resulting from IHT were likely or almost 
certain for serum iron and % Ferritin saturation at both post-intervention days. 
 
Hydration Status 
Participants were at similar levels of hydration, as measured by urine specific 
gravity, prior to all performance exercise trials (IHT group 1.01 ± 0.00, 1.01 ± 
0.00, 1.01 ± 0.01; Placebo group 1.01 ± 0.01, 1.01 ± 0.01, 1.01 ± 0.01 for 
baseline, post2 and post9 tests respectively; mean ± SD). 
 
 
 
 
 
 
 
 
 
Table 4. Mean change in haematological measures post-training, and chances that the true differences in the 
changes are substantial. 
 % Change Chances that true differences 
 Days Post-   Difference; are substantial
a
 
 training IHT Placebo ± 95% CL % Qualitative 
Haemoglobin  2 
9 
1.5 
0.3 
-1.5 
0.1 
3.0; ± 4.0 
0.2; ± 3.6 
75 
20 
Likely 
Unclear 
Haematocrit 2 
9 
2.4 
0.4 
-1.3 
-0.1 
3.7; ± 3.5 
0.5; ± 3.6 
98 
61 
Very likely 
Unclear 
Reticulocytes 2 
9 
2.1 
-18.0 
-7.9 
-2.2 
10.0; ± 16.4 
-15.8; ± 16.1 
85 
96 
Likely 
Very likely 
Serum Iron 2 
9 
-17.7 
-21.6 
10.1 
28.5 
-27.8; ± 40.4 
-50.1; ± 37.1 
90 
99 
Likely 
Almost certainly 
% Ferritin saturation 2 
9 
-17.1 
-18.3 
10.0 
27.3 
-27.1; ± 38.6 
-45.7; ± 37.9 
90 
99 
Likely 
Almost certainly 
Serum Ferritin 2 
9 
-12.2 
-16.3 
-11.9 
-6.3 
-0.3; ± 24.4 
-10.0; ± 21.2 
48 
81 
Unclear 
Unclear 
a
Based on a smallest substantial change of 0.2 of the between-subject standard deviation for all blood measures. 
 ± 95% CL: add and subtract this number to the mean effect to obtain confidence limits for the true difference. 
 
 
 
DISCUSSION 
 
The main novel finding of this study was that 10 consecutive days of IHT 
substantially enhanced anaerobic power during a 30-s Wingate cycle test. We 
also found substantial increases in haemoglobin concentration, haematocrit 
and reticulocyte count 2 days and substantial reductions in serum iron and 
transferrin 2 and 9 days following IHT. In addition, relative to the placebo 
group, the IHT group‟s blood lactate concentration and SpO2 were 
substantially higher during the 20-km time trial. Furthermore, the RER was 
substantially higher during both the 20-km time trial and 30-s Wingate test in 
the IHT compared to the placebo group. Effects on all other measures were 
unclear. When considering the smallest worthwhile effects, the performance 
enhancement found with 30-s mean anaerobic power is likely to be beneficial 
for well-trained multisport athletes or cyclists. 
 
A larger than expected error of measurement is probably a major reason 
behind the lack of clarity in many results. The error of measurement for the 
performance measures in this study ranged from ~ 2% for 30-s mean power 
to ~ 8% for oxygen cost, compared to much lower errors in similar measures 
from previous studies ~ 1-2% (Hamlin & Hellemans 2007; Wood, Dowson 
2006). The larger error measurement in this study could be due to the cycle 
erogometry being less reliable than running which was used to assess 
performance in previous studies (Hamlin & Hellemans 2007; Wood, Dowson 
2006). Because of these larger errors of measurement, we would require a 
larger sample size (>n = 30) to get clear outcomes when the true effect is a 
change in performance of approximately 2%. 
 
Except for 30-s peak power, individual responses to IHT at 2 days post-
intervention were negligible; however at 9 days post-intervention, large 
individual responses were evident, particularly for 30-s peak and 20-km mean 
power. Considering the hypoxic dose was individualised and the training was 
closely monitored this is an unexpected outcome. At least some of the large 
individual response may have been due to the larger than expected standard 
error of measurement of the performance tests at these time periods. It is 
suggested that such test-retest measurement errors should be no more than 
2% (Hopkins et al. 2001), which was obtained for 30-s mean power in this 
study but was higher for the other performance measures. 
 
Although we attempted to individually clamp SpO2 by manually altering FIO2 
the IHT subjects showed considerable variation in SpO2 levels particularly 
toward the end of the training period (Figure 1.) Under poikilocapnic 
conditions (i.e. where the PETCO2 is uncontrolled), hypoxia stimulates 
hyperventilation via the peripheral chemoreflex (Ainslie et al. 2007). However, 
the degree of ventilatory-drive to hypoxia is subject to considerable variation 
(Ainslie & Poulin 2004). This variability may be one reason for the variation 
witnessed in the IHT subjects SpO2 levels. Some variation is probably also 
attributable to the breathing set-up used in this study which included two 100 
L Douglas bags connected in series. Such a set-up introduces a large gas 
reservoir and results in some lag-time in the system between changes in 
individual SpO2 levels of the subjects and subsequent adjustment of FIO2 
levels by the researchers. 
 
Anaerobic Results 
Historically, altitude research has investigated changes in aerobic responses 
to exercise; more recently however, interest has grown into the effects of 
altitude training on anaerobic ability. The results of the present study 
demonstrated that IHT overall benefited the anaerobic more than the aerobic 
performance capacity. Observed changes in mean 30-s power found in this 
study (~ 3%) were similar to those found by others using similar Wingate 
protocols but on LODE ergometers (i.e. maximal pedalling against a constant 
load) (3-4%) (Meeuwsen et al. 2001) (~ 4%) (Hendriksen & Meeuwsen 2003), 
but lower than mean power in repeated sprint tests (~ 7-8%) (Bonnetti, 
Hopkins 2006; Wood, Dowson 2006). The difference in the magnitude of the 
change in mean power between the 30-s Wingate and the repeated sprint 
tests is probably due to the increased aerobic energy system component used 
during repetitive sprinting (Bishop & Edge 2006).  
 
As has been shown in sea-level studies, improvement in anaerobic energy 
supply systems requires high-intensity intermittent training (Lindsay et al. 
1996). Therefore, we hypothesized that in addition to the hypoxic aerobic 
training, the specific anaerobic training during hypoxia would provide a greater 
stimulus for improvement in anaerobic performance. While the present data 
indicates that IHT is advantageous for sea-level anaerobic performance it also 
shows that the specific high-intensity anaerobic training we used added little 
benefit to anaerobic performance change found with low-intensity hypoxic 
training alone (Hendriksen & Meeuwsen 2003; Meeuwsen, Hendriksen 2001). 
With the addition of two maximal 30-s Wingate tests, we based the hypoxic 
training programme of this study on that of (Hendriksen & Meeuwsen 2003) 
who used 120 min cycling at 60-70% heart rate reserve. It has been 
suggested that performance improvements are not likely to occur when 
hypoxic training sessions are of insufficient duration or intensity (Ponsot, 
Dufour 2006). It may well be that the 90 min of aerobic exercise or the very 
short anaerobic exercise (approximately 1 min at maximum power output) 
used daily in this study was insufficient in duration or intensity to show clear 
and substantial increases in the other performance measures. The optimum 
dose and duration of IHT is still unclear. 
 
Time Trial Results 
Controversy exists as to the benefits of intermittent hypoxia on sea-level 
aerobic performance. The current study found a small (~ 2-3%) but unclear 
improvement in 20-km time trial average power output in the IHT compared to 
the placebo group. Ventura and colleagues (2003) also reported a non-
significant (unclear) improvement in maximal power output of approximately 
4% in the IHT relative to the placebo group (Ventura et al. 2003), while other 
researchers have found clear improvements in endurance performance of 
similar magnitude after IHE (~ 2-3 %) (Hamlin & Hellemans 2007; Wood, 
Dowson 2006) or IHT (~ 1-4 %) (Dufour, Ponsot 2006; Hendriksen & 
Meeuwsen 2003; Meeuwsen, Hendriksen 2001). A recent study on kayakers 
found a very large and clearly beneficial increase in peak aerobic power of ~ 
7% three days post IHE intervention (Bonnetti, Hopkins 2006), however 
others have shown aerobic performance decrements ranging from ~ 1-7% 
after IHE (Julian, Gore 2004), or IHT (Morton & Cable 2005; Roels, Bentley 
2007). It is difficult to reconcile these contrasting results, however 
methodological differences between studies may explain some of this 
dissimilarity. Most studies that have reported a drop in performance after IHT 
have used a considerably shorter hypoxic dose. For example, in the present 
study, and others that have shown performance enhancement after IHT 
(Hendriksen & Meeuwsen 2003; Meeuwsen, Hendriksen 2001) subjects 
exercised in a hypoxic state for at least 90 min per day, whereas subjects in 
studies where performance declined after IHT (Morton & Cable 2005; Roels, 
Bentley 2007) participants only exercised in hypoxia for up to 30 min per day. 
It has been suggested that the duration of hypoxic exposure is the most 
important factor when considering the effects of hypoxia on erythropoietin 
release (Knaupp et al. 1992). If this is also the case for the mechanisms that 
are responsible for performance enhancement after hypoxic exposure it may 
explain the disparity in performance results between studies. However, other 
factors such as participant‟s initial athletic ability, variability of the duration and 
intensity of the hypoxic training employed, and exercise training intensities 
during hypoxia are all likely to play a role (Levine 2002). For example, Dufour 
et al. (2006) found an improvement in time to exhaustion of ~ 25% (~ 2% 
equivalent change in power output) in the IHT compared to placebo group 
with only moderate duration (48-80 min per week) but high intensity (second 
ventilatory threshold) hypoxic training (Dufour, Ponsot 2006).  
 
In addition, compared to many of the reports that failed to show any 
performance enhancement with intermittent hypoxic protocols (Julian, Gore 
2004; Morton & Cable 2005; Roels, Bentley 2007), the current study along 
with others that have found substantial improvements in performance 
(Bonnetti, Hopkins 2006; Wood, Dowson 2006), used an individualised 
hypoxic dose, thereby somewhat overcoming the individuals‟ variability in 
response to hypoxia (Ainslie, Barach 2007) which may limit the benefit of the 
hypoxic exposures to athletic performance. Future research in this area 
should include investigation into optimal hypoxic dosage (both duration and 
intensity), effects of individualising the hypoxic dosage, and effects of initial 
fitness levels and training protocols during the hypoxic period. 
  
Physiological Responses 
Mechanisms underlying the improved sea level performance after altitude 
training have received much debate recently (Gore & Hopkins 2005; Levine & 
Stray-Gundersen 2005). Some investigators suggest the enhanced sea-level 
performance is due to the hypoxic conditions causing an increase in red cell 
volume along with an associated increase in maximum oxygen uptake thereby 
allowing a greater oxygen delivery to, and uptake by, the working muscles 
(Levine & Stray-Gundersen 1997). Alternatively, other researchers have 
suggested the hypoxic-induced performance enhancement at sea level is 
caused by changes in the skeletal muscles buffering capacity (Gore, Hahn 
2001) or improved exercise efficiency through producing more ATP per 
molecule of oxygen consumed (Katayama, Sato 2004). 
 
Changes in the blood parameters in this study were similar to previous IHE 
(Hamlin & Hellemans 2007; Rodriguez et al. 2000) and IHT studies 
(Hendriksen & Meeuwsen 2003; Meeuwsen, Hendriksen 2001) and would 
tend to support enhanced erythropoiesis after IHT. When the relationship 
between changes in haemoglobin and mean power output during the time trial 
were analysed via linear regression analysis, we found large correlations at 
day 2 (r = 0.60), and 9 (r = 0.48) post-intervention, suggesting the small 
increase in mean power output after IHT may be explained in part by 
increased haemoglobin concentration. 
 
Previous investigations have shown that intermittent hypoxic exposure results 
in increased ventilation and consequently elevated SaO2 during exercise 
(Ainslie et al. 2008; Katayama et al. 2001). Calculating the overall mean 
changes in the respiratory variables during the 20-km time trial, the results of 
this study similarly indicate increased ventilation and SpO2. It has been 
suggested that IHT causes increased chemoreflex sensitivity to hypoxia 
(Ainslie, Hamlin 2008; Katayama, Sato 2001) resulting in increased ventilation 
and therefore a smaller drop in SpO2 during exercise. 
 
Intermittent hypoxia may also have an effect at the cellular level, altering 
mitochondrial energy production. As suggested by Katayama et al. (2004) this 
change may increase the amount of ATP produced per mole of oxygen 
consumed, thereby resulting in less oxygen required for the same amount of 
energy produced.  Although not conclusive, but similar to previous studies 
(Gore, Hahn 2001; Green et al. 2000; Katayama et al. 2003), our results 
showed a trend downward in oxygen cost (i.e. improved cycling economy) in 
the IHT compared to the placebo group during the time trial. However, this 
result was unclear and should be considered preliminary until further research 
has been completed. 
 
It has been suggested that the improved economy after hypoxic exposure is 
related to the decreased cost of ventilation (Green, Roy 2000). Indeed, in this 
study, at the final stage of the time trial 2 days post-intervention, V E and V O2 
were lower in the IHT compared to the placebo participants, however, this 
change in V E was too variable to make firm conclusions about whether the 
decreased V O2 was due to reduced V E. 
 
A lower V O2 may also arise from a shift toward increased glycolytic 
contribution in ATP production (Katayama, Sato 2004), a move towards 
greater carbohydrate and less fat utilisation in oxidative phosphorylation 
(Roels et al. 2007), a more efficient excitation-contraction process during 
exercise (Green, Roy 2000) or a shift in the mitochondrial regulation to a more 
oxidative profile (Ponsot, Dufour 2006). While the last two hypotheses were 
not able to be tested in this study some evidence exists for a hypoxia-induced 
change in metabolism. At 2 days post-intervention we found a shift in the RER 
in the IHT compared to the placebo group that would indicate greater 
carbohydrate utilisation during both 30-s and 20-km exercise. We found a 
moderate to large negative correlation (r = -0.47) between RER and oxygen 
cost at day 2, reducing to a small to moderate correlation at 9 days post-
intervention (r = -0.16). These data, while not conclusive, suggest that after 
IHT, the reduced oxygen cost during the time trial may be explained in part, 
by a shift toward carbohydrate utilization. Further evidence for this shift comes 
from the substantial increase in blood lactate production in the IHT compared 
to the placebo group during the time trial. Recently Peronnet et al. (2006) also 
found substantial increases in blood lactate concentration accompanying a 
shift in carbohydrate utilization in subjects exercising in hypoxic conditions 
(Peronnet et al. 2006). These data are consistent with the suggestion that 
under hypoxic conditions, increased carbohydrate flux reflects a shift towards 
carbohydrate utilization which is a more efficient fuel in terms of ATP 
generation per mole of O2 consumed (Hahn & Gore 2001). 
 
In conclusion, the results of this study demonstrate that training in a hypoxic 
environment for ~91 min per day for 10 consecutive days resulted in a clear 
3.0% improvement in mean 30-s power 2 days post-intervention, and 
beneficial but unclear changes in 30-s peak power, 20-km mean power and 
20-km oxygen cost 2 and 9 days post-intervention. Changes in the 
physiological and haematological indices indicate IHT may work to increase 
the blood oxygen carrying capacity but also change the metabolic fuel source 
towards enhanced breakdown of carbohydrate. 
 
 
PRACTICAL IMPLICATIONS 
 
Many athletes continue to use live-low, train-high techniques to improve sea-
level performance. Such training is controversial with a recent review stating 
such training cannot be recommended for athletes because of a lack of 
sufficient evidence (Hoppeler et al. 2008). The results of the current study add 
little to resolve the debate on whether live-low train-high improves endurance 
performance. However, our results do indicate that the true effect of such 
training on anaerobic performance (30-s Wingate test) of well-trained athletes 
can be a change in performance anywhere from a small decrease of 0.5% 
through to a large increase of 6.5% (95% confidence interval). The chances 
that the true effects are beneficial was 91%, whereas the chances that this 
effect is detrimental was 1%. Given these odds, most well-trained athletes 
would be likely to benefit from such training. However, it remains to be seen 
whether such changes also occur in very elite athletes. 
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